We are live on ! Find out more
COYA icon

Coya Therapeutics

19 hedge funds and large institutions have $33.1M invested in Coya Therapeutics in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 3 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 3

111% more capital inflows, than outflows

Capital inflows: $8.12M | Capital outflows: $3.86M

5.17% less ownership

Funds ownership: 28.14% → 22.96% (-5.2%)

10% less funds holding

Funds holding: 21 → 19 (-2)

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

Holders
19
Holders Change
-2
Holders Change %
-9.52%
% of All Funds
0.27%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
3
Increased
9
Reduced
3
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

COYA Hedge Fund Activity: Q1 2024 in Review

19 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Coya Therapeutics (COYA) for Q1 2024, worth a combined $33.1M — up 60% from $20.6M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of COYA and 3 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 9 added.

The largest buyer was Vanguard Group, adding an estimated $5.88M. The largest seller was AIGH Capital Management, cutting an estimated $3M.

  • 19 institutional investors held Coya Therapeutics (COYA) as of Q1 2024, down from 21 in Q4 2023.
  • Funds reported $33.1M of Coya Therapeutics stock for Q1 2024, up 60% quarter-over-quarter.
  • 3 funds opened new Coya Therapeutics positions in Q1 2024 and 4 closed out, a net change of -1 holder.
  • The largest Coya Therapeutics buyer in Q1 2024 was Vanguard Group, an estimated $5.88M added.
  • The largest Coya Therapeutics seller in Q1 2024 was AIGH Capital Management, an estimated $3M sold.

Based on aggregated 13F filings for Q1 2024.